In vitro and in vivo studies of novel indoles that exert antimitotic activity in prostate cancer and multidrug-resistant tumor cells with less neurotoxicity

被引：0
|
作者：
Ahn, Sunjoo
Duke, Charles
Hwang, Dong-Jin
Miller, Duane
Dalton, James
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Univ Tennessee, Memphis, TN 38163 USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3326
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Antimitotic agents with activity in multidrug-resistant tumor cell lines.
    Szczepankiewicz, BG
    Liu, G
    Tasker, AS
    Sorensen, BK
    von Geldern, TW
    Jae, HS
    Winn, M
    Gwaltney, SL
    Kester, JA
    Pei, ZH
    Wu-Wong, JR
    Gehrke, L
    Chiou, WJ
    Credo, RB
    Lee, JY
    Warner, RB
    Alder, JD
    Nukkala, MA
    Zielinski, NA
    Marsh, KC
    Rosenberg, SH
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U25 - U25
  • [2] Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo
    Hofstetter, B
    Vuong, V
    Broggini-Tenzer, A
    Bodis, S
    Ciernik, IF
    Fabbro, D
    Wartmann, M
    Folkers, G
    Pruschy, M
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1588 - 1596
  • [3] I-387, a Novel Antimitotic Indole, Displays a Potent In vitro and In vivo Antitumor Activity with Less Neurotoxicity
    Ahn, Sunjoo
    Duke, Charles B., III
    Barrett, Christina M.
    Hwang, Dong Jin
    Li, Chien-Ming
    Miller, Duane D.
    Dalton, James T.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (11) : 2859 - 2868
  • [4] ACTIVITY OF THE PYRAZOLOACRIDINES AGAINST MULTIDRUG-RESISTANT TUMOR-CELLS
    SEBOLT, J
    HAVLICK, M
    HAMELEHLE, K
    NELSON, J
    LEOPOLD, W
    JACKSON, R
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (04) : 219 - 224
  • [5] D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity
    Bacher, G
    Nickel, B
    Emig, P
    Vanhoefer, U
    Seeber, S
    Shandra, A
    Klenner, T
    Beckers, T
    [J]. CANCER RESEARCH, 2001, 61 (01) : 392 - 399
  • [6] Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro
    Naoe, Y
    Inami, M
    Takagaki, S
    Matsumoto, S
    Kawamura, I
    Nishigaki, F
    Tsujimoto, S
    Manda, T
    Shimomura, K
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (10): : 1047 - 1054
  • [7] GTx-230: an orally available novel tubulin inhibitor that disrupts tumor vasculature and displays single-agent antitumor efficacy in multidrug-resistant prostate cancer with less neurotoxicity
    Ahn, Sunjoo
    Li, Chien-Ming
    Barrett, Christina M.
    Chen, Jianjun
    Li, Wei
    Lu, Yan
    Miller, Duane D.
    Dalton, James T.
    [J]. CANCER RESEARCH, 2012, 72
  • [8] Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells
    Guo, Yong-En
    Chen, Hong
    Zuo, Song
    Liu, Dai-Lin
    Lu, Yan-Ling
    Lv, Jing-Jing
    Wen, Shao-Peng
    Zhang, Tong-Cun
    [J]. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2011, 13 (05) : 417 - 424
  • [9] Antineoplastic activity of heterocyclic compounds in multidrug-resistant cancer cells
    Lage, Hermann
    Kubald, Sybille
    Jella, Kishore Kumar
    Yalcin, Ismail
    Aki-Sener, Esin
    [J]. DRUGS OF THE FUTURE, 2007, 32 : 27 - 28
  • [10] MODULATION OF DOXORUBICIN-TOXICITY BY TAMOXIFEN IN MULTIDRUG-RESISTANT TUMOR-CELLS IN-VITRO AND IN-VIVO
    POMMERENKE, E
    MATTERN, J
    VOLM, M
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1994, 120 (07) : 422 - 426
12345